Company to Highlight Next Stage of PH-762 Clinical Development in Cutaneous Squamous Cell CarcinomaKing of Prussia, Pennsylvania--(Newsfile Corp. -) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a ...
Freiburg, Germany, September 15, 2026 – One04 Therapeutics GmbH & Co. KG today announced its launch as a clinical-stage biopharmaceutical company with encouraging Phase 1 results for CPV-104, a ...
Engitix Ltd., a biotechnology company pioneering extracellular matrix (ECM)-based discovery platforms to transform drug development in oncology, fibrosis and fibro‑inflammatory disease, today ...
Boost ROI through drug-diagnostic partnerships, NGS and liquid biopsy innovation, AI-enabled biomarker discovery, and Asia-Pacific expansion.Dublin, Sept. (GLOBE NEWSWIRE) -- "Companion Diagnostics ...
MaaT Pharma has scheduled a Pre-IND CMC-focused meeting with the FDA in October 2026, the next regulatory milestone toward ...
Retension Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular conditions. The company’s lead ...
Award supports development of automated clinical consistency checking to strengthen safety monitoring across trial data ...
As the biotech world flocks to San Diego today for the BIO International Convention, the Department of Health and Human Services has provided plenty of conversation fodder with the announcement of a ...
Holding more than 25 years of experience in the medical sector spread across numerous pharmaceutical and CRO-based clinical research roles, Edel Shaw knows a thing or two about drug development. Based ...
IMUNON Inc. ( IMNN ), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, announced it has entered into a Cooperative Research and Development Agreement (CRADA) with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results